Time window in cholinomimetic ability to rescue long-term potentiation in neurodegenerating anti-nerve growth factor mice

Journal of Alzheimer's Disease

Volumn 9, Issue 1, 2006, Pages 59-68

  Origlia, Nicola ^a,b   Capsoni, Simona ^b   Domenici, Luciano ^a,c,d   Cattaneo, Antonino ^e  

^a SISSA   (Italy)

^b Lay Line Genomics SpA   (Italy)

^c CNR   (Italy)

^d UNIVERSITY OF L'AQUILA   (Italy)

^e EUROPEAN BRAIN RESEARCH INSTITUTE   (Italy)

Author keywords

Acetylcholine; Galantamine; LTP; NGF deprivation; Transgenic mice

Indexed keywords

ACETYLCHOLINE; AMYLOID PROTEIN; GALANTAMINE; NERVE GROWTH FACTOR ANTIBODY; RECOMBINANT NERVE GROWTH FACTOR;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BEHAVIOR DISORDER; BRAIN CORTEX; CHOLINERGIC ACTIVITY; CHOLINERGIC NERVE CELL; CHOLINERGIC SYSTEM; COGNITIVE DEFECT; CONTROLLED STUDY; DISEASE COURSE; FOREBRAIN; LONG TERM POTENTIATION; MOUSE; NEOCORTEX; NERVE CELL PLASTICITY; NERVE DEGENERATION; NEUROFIBRILLARY TANGLE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE;

EID: 33646004298     PISSN: 13872877     EISSN: None     Source Type: Journal    
DOI: 10.3233/JAD-2006-9106     Document Type: Article

References (33)

1. E.X. Albuquerque, M. Alkondon, E.F. Pereira, N.G. Castro, A. Schrattenholz, C.T. Barbosa, R. Bonfante-Cabarcas, Y. Aracava, H.M. Eisenberg and A. Maelicke, Properties of neuronal nicotinic acetylcholine receptors: pharmacological characterization and modulation of synaptic function, J. Pharmacol. Exp. Ther. 280 (1997), 1117-1136.
2. A. Alvarez, C. Opazo, R. Alarcon, J. Garrido and N.C. Inestrosa, Acetylcholinesterase promotes the aggregation of amyloid-beta-peptide fragments by forming a complex with the growing fibrils, J. Mol. Biol. 272 (1997), 348-361.
3. W.W. Anderson and G.L. Collingridge, The LTP Program: a data acquisition program for on-line analysis of long-term potentiation and other synaptic events, J. Neurosci. Methods. 108 (2001), 71-83.
4. R.T. Bartus, R.L. Dean, B. Beer and A.S. Lippa, The cholinergic hypothesis of geriatric memory dysfunction, Science 217 (1982), 408-414.
5. H. Braak and E. Braak, Neuropathological stageing of Alzheimer-related changes, Acta Neuropathol. (Berl.) 82 (1991), 239-259.
6. G.M. Bores, F.P. Huger, W. Petko, A.E. Mutlib, F. Camacho, D.K. Rush, D.E. Selk, V. Wolf, R.W. Kosley, L. Davis and H.M. Vargas, Pharmacological evaluation of novel Alzheimer's disease therapeutics: acetylcholinesterase inhibitors related to galantamine, J. Pharmacol. Exp. Ther. 277 (1996), 728-738.
7. S. Capsoni, G. Ugolini, A. Comparini, F. Ruberti, N. Berardi and A. Cattaneo, Alzheimer-like neurodegeneration in aged antinerve growth factor transgenic mice, Proc. Natl. Acad. Sci. USA 97 (2000), 6826-6831.
8. S. Capsoni, S. Giannotta and A. Cattaneo, Early events of Alzheimer-like neurodegeneration in anti-nerve growth factor transgenic mice, Brain Aging 2 (2002), 24-43.
9. S. Capsoni, S. Giannotta and A. Cattaneo, Nerve growth factor and galantamine ameliorate early signs of neurodegeneration in anti-nerve growth factor mice, Proc. Natl. Acad. Sci. USA 99 (2002), 12432-12437.
10. A. Cattaneo, S. Capsoni, E. Margotti, M. Righi, E. Kontsekova, P. Pavlik, P. Filipcik and M. Novak, Functional blockade of tyrosine kinase A in the rat basal forebrain by a novel antagonistic anti-receptor monoclonal antibody, J. Neurosci 19 (1999), 9687-9697.
11. Q.S. Chen, W.Z. Wie, T. Shimahara and C.W. Xie, Alzheimer amyloid beta-peptide inhibits the late phase of long-term potentiation through calcineurin-dependent mechanisms in the hippocampal dentate gyrus, Neurobiol. Learn. Mem. 77 (2002), 354-371.
12. R. De Rosa, A.A. Garcia, C. Braschi, S. Capsoni, L. Maffei, N. Berardi and A. Cattaneo, Intranasal administration of nerve growth factor (NGF) rescues recognition memory deficits in AD11 anti-NGF transgenic mice, Proc. Natl. Acad. Sci. USA 102 (2005), 3811-3816.
13. C. Geula and M. Mesulam, Special properties of cholinesterases in the cerebral cortex of Alzheimer's disease, Brain Res 498 (1989), 185-189.
14. E. Giacobini, Cholinesterases: new roles in brain function and in Alzheimer's disease, Neurochem. Res. 28 (2003), 515-522.
15. H.M. Huang, H.C. Ou and S.J. Hsieh, Amyloid beta peptide impaired carbachol but not glutamate-mediated phosphoinositide pathways in cultured rat cortical neurons, Neurochem. Res. 25 (2000), 303-312.
16. S. Kar, S.P. Slowikowski, D. Westaway and H.T. Mount, Interactions between beta-amyloid and central cholinergic neurons: implications for Alzheimer's disease, J. Psychiatry Neurosci. 29 (2004), 427-441.
17. N. Kuczewski, E. Aztiria, G. Leanza and L. Domenici, Selective cholinergic immunolesioning affects synaptic plasticity in developing visual cortex, Eur. J. Neurosci. 21 (2005), 1807-1814.
18. R. Levi-Montalcini, The nerve growth factor 35 years later, Science 237 (1987), 1154-1162.
19. Y. Li, D.M. Holtzman, L.F. Kromer, D.R. Kaplan, J. Chua-Couzens, D.O. Clary, B. Knusel and W.C. Mobley, Regulation of TrkA and ChAT expression in developing rat basal forebrain: evidence that both exogenous and endogenous NGF regulate differentiation of cholinergic neurons, J. Neurosci. 15 (1995), 2888-2905.
20. Q. Liu, H. Kawai and D.K. Berg, Beta -Amyloid peptide blocks the response of alpha 7-containing nicotinic receptors on hippocampal neurons, Proc. Natl. Acad. Sci. USA 98 (2001), 4734-4739.
21. A. Maelicke and E.X. Albuquerque, Allosteric modulation of nicotinic acetylcholine receptors as a treatment strategy for Alzheimer's disease, Eur. J. Pharmacol. 393 (2000), 165-170.
22. W.C. Mobley, J.L. Rutkowski, G.I. Tennekoon, J. Gemski, K. Buchanan and M.V. Johnston, Nerve growth factor increases choline acetyltransferase activity in developing basal forebrain neurons, Brain. Res. 387 (1986), 53-62.
23. M. Molnar, E. Tongiorgi, E. Avignone, S. Gonfloni, F. Ruberti, L. Domenici and A. Cattaneo, The effects of anti-nerve growth factor monoclonal antibodies on developing basal forebrain neurons are transient and reversible, Eur. J. Neurosci. 10 (1998), 3127-3140.
24. E.J. Mufson, J.S. Kroin, T.J. Sendera and T. Sobreviela, Distribution and retrograde transport of trophic factors in the central nervous system: functional implications for the treatment of neurodegenerative diseases, Prog. Neurobiol. 57 (1999), 451-484.
25. E. Pesavento, E. Margotti, M. Righi, A. Cattaneo and L. Domenici, Blocking the NGF-TrkA interaction rescues the developmental loss of LTP in the rat visual cortex: role of the cholinergic system, Neuron 25 (2000), 165-175.
26. E. Pesavento, S. Capsoni, L. Domenici and A. Cattaneo, Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice, Eur. J. Neurosci. 15 (2002), 1030-1036.
27. D.L. Pettit, Z. Shao and J.L. Yakel, Beta-Amyloid (1-42) peptide directly modulates nicotinic receptors in the rat hippocampal slice, J. Neurosci. 21 (2001), RC120.
28. F. Ruberti, S. Capsoni, A. Comparini, E. Di Daniel, J. Franzot, S. Gonfaloni, G. Rossi, N. Berardi and A. Cattaneo, Phenotypic knockout of nerve growth factor in adult transgenic mice reveals severe deficits in basal forebrain cholinergic neurons, cell death in the spleen, and skeletal muscle dystrophy, J. Neurosci. 20 (2000), 2589-2601.
29. A. Salehi, J.D. Delcroix and W.C. Mobley, Traffic at the intersection of neurotrophic factor signaling and neurodegeneration, Trends Neurosci 26 (2003), 73-80.
30. D.J. Selkoe, Alzheimer's disease: genes, proteins, and therapy, Physiol. Rev. 81 (2001), 741-766.
31. O.V. Vitolo, A. Sant'Angelo, V. Costanzo, F. Battaglia, O. Arancio and M. Shelanski, Amyloid beta -peptide inhibition of the PKA/CREB pathway and long-term potentiation: reversibility by drugs that enhance cAMP signalling, Proc. Natl. Acad. Sci. USA 99 (2002), 13217-13221.
32. Q. Wang, D.M. Walsh, M.J. Rowan, D.J. Selkoe and R. Anwyl, Block of long-term potentiation by naturally secreted and synthetic amyloid beta-peptide in hippocampal slices is mediated via activation of the kinases c-Jun N-terminal kinase, cyclin-dependent kinase 5, and p38 mitogen-activated protein kinase as well as metabotropic glutamate receptor type 5, J. Neurosci. 24 (2004), 3370-3378.
33. P.J. Whitehouse, D.L. Price, R.G. Struble, A.W. Clark, J.T. Coyle and M.R. Delon, Alzheimer's disease and senile dementia: loss of neurons in the basal forebrain, Science 215 (1982), 1237-1239.